Kenvue Q3 net sales -0.4% to $3.9B, adj EPS $0.28 vs $0.31 YoY, lowers sales growth guidance

Kenvue Inc.

2024-Q3 EPS reported $0.38 revenue$11,793,000,000

Net sales $3.9B, -0.4% YoY; organic growth +0.9% (value realization +2.5%, volume -1.6%).
Diluted EPS $0.20; adjusted diluted EPS $0.28 vs $0.31 YoY; gross margin expanded 100bps to 58.5%.
Self Care drove share gains; Essential Health broad-based growth; Skin Health and Beauty early recovery signs.
2024 outlook: net sales & organic growth guidance lowered to low end of ranges (1-3% & 2-4%); adj EPS reaffirmed $1.10-$1.20.
Adjusted operating margin 22.1% vs 23.3% YoY due to increased brand investment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.